882 studies found for:    "Hepatitis C, Chronic"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis C, Chronic"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Irbesartan;   Drug: placebo
2 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
3 Active, not recruiting A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Ribavirin
4 Completed Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention: Drug: peginterferon alfa-2a and ribavirin
5 Completed Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
Conditions: HIV Infections;   Hepatitis C, Chronic;   Treatment Failure
Interventions: Drug: Peginterferon alfa2a;   Drug: Ribavirin
6 Completed
Has Results
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 18908)
7 Unknown  Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: PEG-rIL-29;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
8 Recruiting Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
Conditions: RNA Virus Infections;   Flaviviridae Infections;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Vitamin D;   Drug: Vitamin B 12
9 Completed Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-interferon alpha 2a (drug);   Drug: Ribavirin (drug);   Drug: Interferon gamma (drug)
10 Completed Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Conditions: Hepatitis C, Chronic;   Liver Fibrosis
Interventions: Biological: Peginterferon alfa-2b;   Drug: Ribavirin;   Drug: Ribavirin-Placebo
11 Withdrawn Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention:
12 Completed Multidisciplinary Support Program in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Other: Multidisciplinary support program
13 Completed Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
Conditions: Hepatitis C, Chronic;   Cognition Disorders;   Fatigue Syndrome, Chronic;   Major Depressive Disorder
Intervention: Drug: Interferon and ribavirin
14 Recruiting Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Intervention: Biological: VGX-6150
15 Active, not recruiting Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2878175;   Drug: Placebo
16 Completed Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2336805;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin;   Drug: GSK2336805 Matching Placebo
17 Recruiting Effect of Camel Milk on Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon,  Ribavirin, camel milk;   Drug: Peginterferon,  Ribavirin
18 Completed Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Liver Fibrosis
Intervention: Drug: Losartan
19 Unknown  HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Oral HDV-Interferon + ribavarin;   Drug: Injectable HDV-Interferon + ribavarin
20 Completed Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ypeginterferon alfa-2b;   Drug: Peginterferon alfa-2a

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years